NCT01760005: Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001
- State
- Under way
- Phase
- Phase 2 and Phase 3
- People
- 490 planned
- Started
- Dec 2012
- Primary completion
- Apr 2028
- Arms
- Matching placebo (E2814) plus lecanemab
- Results
- None posted
- Papers
- doi:10.1002/alz.70689, doi:10.1007/s00259-023-06209-0, doi:10.1016/s1474-4422(25)00024-9, doi:10.1101/2024.10.29.24316289
- 3 Jan 2013: Trial registered